130 related articles for article (PubMed ID: 22315118)
41. Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC). A case report.
Subramanian J; Pillot G; Narra V; Govindan R
Lung Cancer; 2006 Feb; 51(2):257-9. PubMed ID: 16387387
[TBL] [Abstract][Full Text] [Related]
42. EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans.
Arteaga CL
Cancer Cell; 2006 Jun; 9(6):421-3. PubMed ID: 16766261
[TBL] [Abstract][Full Text] [Related]
43. Surgical resection of lung adenocarcinoma without EGFR mutation after neoadjuvant gefitinib treatment.
Shen H; Zhong X; Ge XQ; Huang JJ; Yuan Y
Clin Respir J; 2010 Jul; 4(3):192-3. PubMed ID: 20565499
[No Abstract] [Full Text] [Related]
44. Two rare exon 21 EGFR mutations in patients treated with gefitinib.
Mompradé E; Arriola E; Martínez-Avilés L
J Thorac Oncol; 2013 Apr; 8(4):e36-7. PubMed ID: 23486275
[No Abstract] [Full Text] [Related]
45. The use of octreotide to manage symptoms of bronchorrhea: a case report.
Pahuja M; Shepherd RW; Lyckholm LJ
J Pain Symptom Manage; 2014 Apr; 47(4):814-8. PubMed ID: 24035070
[TBL] [Abstract][Full Text] [Related]
46. Computer-assisted image analysis of bronchioloalveolar carcinoma.
Lau D; Seibert A; Gandara D; Laptalo L; Geraghty E; Coulon C
Clin Lung Cancer; 2005 Mar; 6(5):281-6. PubMed ID: 15845178
[TBL] [Abstract][Full Text] [Related]
47. Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
Erickson TM; Koeppe JR; Miller YE; Stuart RW; Camidge DR
J Thorac Oncol; 2008 Nov; 3(11):1353-5. PubMed ID: 18978572
[TBL] [Abstract][Full Text] [Related]
48. High-resolution CT findings of mucinous bronchioloalveolar carcinoma: a case of pseudopulmonary alveolar proteinosis.
Tan RT; Kuzo RS
AJR Am J Roentgenol; 1997 Jan; 168(1):99-100. PubMed ID: 8976928
[No Abstract] [Full Text] [Related]
49. Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.
Hsieh RK; Lim KH; Kuo HT; Tzen CY; Huang MJ
Chest; 2005 Jul; 128(1):317-21. PubMed ID: 16002952
[TBL] [Abstract][Full Text] [Related]
50. [Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone].
Hiratsuka T; Mukae H; Ihiboshi H; Ashitani J; Katoh S; Mashimoto H; Hirosako S; Mizobe T; Matsumoto M; Matsukura S
Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):482-7. PubMed ID: 9742869
[TBL] [Abstract][Full Text] [Related]
51. Predictors of the response to gefitinib in refractory non-small cell lung cancer.
Kim KS; Jeong JY; Kim YC; Na KJ; Kim YH; Ahn SJ; Baek SM; Park CS; Park CM; Kim YI; Lim SC; Park KO
Clin Cancer Res; 2005 Mar; 11(6):2244-51. PubMed ID: 15788673
[TBL] [Abstract][Full Text] [Related]
52. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.
Garfield DH; Cadranel JL; Wislez M; Franklin WA; Hirsch FR
J Thorac Oncol; 2006 May; 1(4):344-59. PubMed ID: 17409882
[TBL] [Abstract][Full Text] [Related]
53. Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
Lim SH; Lee JY; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2014 Apr; 9(4):506-11. PubMed ID: 24736073
[TBL] [Abstract][Full Text] [Related]
54. Bronchioloalveolar cell carcinoma presenting as a "non-resolving consolidation" for two years.
Mir E; Sareen R; Kulshreshtha R; Shah A
Pneumonol Alergol Pol; 2015; 83(3):208-11. PubMed ID: 26050981
[TBL] [Abstract][Full Text] [Related]
55. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
[TBL] [Abstract][Full Text] [Related]
56. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
57. [Bronchorrhea in a case of pneumonic type of bronchioloalveolar carcinoma].
Zielonka TM; Lesiński J; Zukowska M; Domagała-Kulawik J; Kaperski L; Przybyłowski T; Chazan R
Pol Arch Med Wewn; 2004 Aug; 112(2):961-7. PubMed ID: 15675272
[TBL] [Abstract][Full Text] [Related]
58. Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.
Erman M; Grunenwald D; Penault-Llorca F; Grenier J; Besse B; Validire P; Morat L; Girard P; Le Chevalier T; Sabatier L; Soria JC
Lung Cancer; 2005 Mar; 47(3):315-23. PubMed ID: 15713515
[TBL] [Abstract][Full Text] [Related]
59. Are there imaging characteristics associated with epidermal growth factor receptor and KRAS mutations in patients with adenocarcinoma of the lung with bronchioloalveolar features?
Glynn C; Zakowski MF; Ginsberg MS
J Thorac Oncol; 2010 Mar; 5(3):344-8. PubMed ID: 20087229
[TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
